Research Topics
Species | J C ChevilleSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Chromophobe renal cell carcinoma: the impact of tumor grade on outcomeJohn C Cheville
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Am J Surg Pathol 36:851-6. 2012....
Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancerDagmar M Kube
Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
BMC Mol Biol 8:25. 2007..Here we present methods developed, optimized, and validated to obtain high quality gene expression data...
Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcomeJohn C Cheville
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Am J Surg Pathol 28:435-41. 2004..59; P = 0.010) and after adjusting for TNM stage, tumor size, and histologic tumor necrosis (risk ratio 1.46; P = 0.037)...
pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survivalJohn C Cheville
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 94:2180-4. 2002....
MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumorsJ C Cheville
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Mod Pathol 12:974-8. 1999..The significance of MAGE-1 and MAGE-3 proteins in normal spermatogonia and primary spermatocytes will require additional study...
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinomaJohn C Cheville
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 27:612-24. 2003..Our results demonstrate that there are significant differences in outcome and associations with outcome for the different histologic subtypes of RCC, highlighting the need for accurate subtyping...
Classification and pathology of testicular germ cell and sex cord-stromal tumorsJ C Cheville
Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA
Urol Clin North Am 26:595-609. 1999..The urologist can provide the pathologist with key clinical information in the attempt to make a correct diagnosis...
Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survivalJohn C Cheville
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 95:1028-36. 2002..The objective of this study was to examine the clinical and pathologic features of metastatic prostate carcinoma to bone in a large cohort of men, and the associations of these features with outcome...
Extranodal extension in lymph node-positive prostate cancerL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Mod Pathol 13:113-8. 2000..In contrast, nodal cancer volume was predictive of distant metastasis-free survival and cancer-specific survival...
Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative seruT J Sebo
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 91:2196-204. 2001....
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomyDavid S Dimarco
Department of Urology, Mayo Clinic, Rochester, Minnesota 55901, USA
Urology 64:462-7. 2004..Multifocality was not significantly associated with ipsilateral recurrence or death from RCC. In addition, multifocality was not associated with larger and higher stage tumors, as previously reported...
Paraganglioma of the urinary bladder: can biologic potential be predicted?L Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Cancer 88:844-52. 2000..Paraganglioma of the urinary bladder is rarely encountered and its biologic behavior is uncertain. The authors sought to determine the prognostic factors that would predict patient outcome...
The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapyL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Clin Cancer Res 6:1896-9. 2000..06 and 0.01, respectively). These findings indicate that p21 and p27 expression levels are significant predictors of survival for patients selected for salvage prostatectomy for recurrent prostate cancer...
Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survivalJ C Cheville
Departments of Pathology and Laboratory Medicine, Urology and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
J Urol 166:453-6. 2001..Specifically of the tumor size cutoffs analyzed the 5 cm. cutoff was most predictive of cancer specific survival...
Diagnosis of prostate cancer in needle biopsies after radiation therapyL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Am J Surg Pathol 23:1173-83. 1999..Conversely, Gleason grade in postirradiation needle biopsy specimens appeared to provide useful predictive information and should be reported...
The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinomaMichael L Blute
Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
J Urol 169:1276-81. 2003..A surgical approach is appropriate for bilateral synchronous renal cell carcinoma and most cases can be approached at a single surgical procedure with acceptable morbidity...
Outcomes following partial nephrectomy by tumor sizePaul L Crispen
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 180:1912-7. 2008..We established long-term survival in patients following partial nephrectomy according to tumor size...
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcomeKent G Krejci
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Urology 62:641-6. 2003..Tumor stage and grade were associated with outcome among patients with localized clear cell RCC. These findings are similar to the results for patients with localized clear cell RCC treated with radical nephrectomy...
Serous borderline tumor of the paratestis: a report of seven casesR F McClure
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 25:373-8. 2001..To date, no serous borderline tumor of the paratestis reported in the literature or in our series has recurred or metastasized after resection...
Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion?L Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Cancer 88:853-61. 2000..Nephrogenic metaplasia with cytologic atypia (atypical nephrogenic metaplasia) is occasionally encountered and its biologic potential is uncertain...
Squamous papilloma of the urinary tract is unrelated to condyloma acuminataL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Cancer 88:1679-86. 2000..To the authors' knowledge, there is no previous report of squamous papilloma of the urinary tract. It is uncertain whether there is a correlation between squamous papilloma, condyloma acuminatum, and verrucous carcinoma...
Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each otherMatthew K Tollefson
Department of Urology, Mayo Clinic and Mayo Medical School, Rochester, MN 55905, USA
Cancer 110:783-90. 2007..Thus, the goal was to directly test whether Ki-67 and necrosis convey similar or distinct information for the prognostic assessment of ccRCC...
Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extensionMatthew T Gettman
Department of Urology, Division of Anatomic Pathology and Section of Biostatistics, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 169:1282-6. 2003..The Charlson index did not predict cause specific survival in this cohort of surgically treated patients. Prospective assessment of co-morbidity in patients treated with surgery versus conservative therapy is warranted...
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN scoreIgor Frank
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
J Urol 168:2395-400. 2002..We present a scoring system based on these features that can be used to predict outcome...
Urothelial papilloma of the bladder. Clinical and biologic implicationsL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Cancer 86:2098-101. 1999..An international consensus has been reached regarding diagnostic criteria for papilloma of the urinary bladder. However, the incidences of recurrence and progression in patients with urothelial papilloma are uncertain...
A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinomaIgor Frank
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
J Urol 170:2225-32. 2003..CONCLUSIONS: We present scoring algorithms based on multivariately significant predictors of site specific recurrence that can be used to tailor postoperative surveillance to the individual patient...
Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgeryReza Ghavamian
Department of Laboratory Medicine, Health Sciences Research and Urology, Mayo Clinic, Rochester, Minnesota, USA
J Urol 168:454-9. 2002..Nephron sparing surgery in a solitary kidney can be performed safely and with minimal morbidity...
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressivenessShomik Sengupta
Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cancer 104:511-20. 2005..90; P < 0.001). CONCLUSIONS: Histologic coagulative tumor necrosis is an independent predictor of outcome for clear cell and chromophobe RCC, and it should be routinely reported and used in clinical assessment...
Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressivenessFarhad Kosari
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin Cancer Res 11:5128-39. 2005..Our data also indicate that the gene expression alterations that result in aggressive behavior and metastatic potential can be identified in the primary tumor...
Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracyR Houston Thompson
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 104:53-60. 2005..61 vs. 0.55, respectively). CONCLUSIONS: Direct adrenal invasion from RCC should be reclassified as pT4. In addition, the proposed reclassification for patients with pT3 RCC improved prognostic accuracy...
Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomyWeber K Lau
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Urology 59:532-7. 2002..CONCLUSIONS: RCC subtype is a strong independent prognostic variable for patients with pT1 RCC treated with radical nephrectomy. For clear cell RCC, Fuhrman grade and tumor size are independently associated with CSS and MFS...
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancersR V Lloyd
Department of Laboratory Medicine and Pathology, Mayo Foundation and Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Pathol 154:313-23. 1999..We also review studies indicating the increasingly important roles of p27, other CDKIs, and cyclins in endocrine cell hyperplasia and tumor development...
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinomaJohn F Ward
Department of Urology, and Section of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
J Urol 168:56-60. 2002..When the tumor is 5 cm. or greater, shows pathological necrosis or is advanced grade 3 or 4, lymph node sampling adds little prognostic information...
Identification of prognostic biomarkers for prostate cancerFarhad Kosari
Mayo Clinic Cancer Center, Department of Laboratory Medicine and Pathology, Rochester, Minnesota 55905, USA
Clin Cancer Res 14:1734-43. 2008..This paper describes a process for the identification of genes that can report on the aggressiveness of prostate tumors and thereby add to the information provided by current pathologic analysis...
Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasionRobert Houston Thompson
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
Am J Surg Pathol 31:1089-93. 2007..Appropriate assessment of nephrectomy specimens should include proper sampling of the renal sinus even for seemingly localized tumors...
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinomaBradley C Leibovich
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 25:4757-64. 2007..We attempted to validate the prognostic utility of CAIX expression using a large cohort of ccRCC patients with long-term follow-up...
Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparisonT E Muir
Department of Laboratory Medicine and Pathology, Mayo Foundation, Rochester, Minnesota 55905, USA
Am J Surg Pathol 25:1290-6. 2001..Metanephric adenoma is histogenetically related to WT and is morphologically and immunophenotypically identical to maturing WT and nephrogenic rests...
Natural history of urothelial dysplasia of the bladderL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Am J Surg Pathol 23:443-7. 1999..The authors conclude that urothelial dysplasia is a significant risk for the development of CIS and invasive urothelial carcinoma, and patients with urothelial dysplasia should be followed up closely...
Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapyShomik Sengupta
Department of Urology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Urology 68:810-4. 2006..Prospective assessment of oncologic outcomes of such an approach is required...
A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinomaChristine M Lohse
Division of Biostatistics, Mayo Clinic, Rochester, MN 55905, USA
Clin Lab Med 25:433-64. 2005..The features that are reported routinely in clinical practice also are indicated; this can serve as a guide for the reporting of results from the pathologic examination of RCC...
High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomasAlexander S Parker
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
Hum Pathol 33:801-5. 2002....
Hypermethylation of genes for diagnosis and risk stratification of prostate cancerDonkena Krishna Vanaja
Department of Urology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
Cancer Invest 27:549-60. 2009..Furthermore, CpG site hypermethylation of genes FLNC, EFS, ECRG4, PITX2, PDLIM4, and KCNMA1 were associated with prediction of biochemical, local, and systemic recurrence of prostate cancer...
Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progressionDonkena Krishna Vanaja
Department of Urology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
Cancer Res 63:3877-82. 2003..Thus, transcriptional silencing of ZNF185 by methylation in prostate tumor tissues implicates the ZNF185 gene in prostate tumorigenesis...
Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomyJohn C Cheville
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
J Clin Oncol 26:3930-6. 2008..The objective of this study was to develop a model predictive of outcome in this group of patients...
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancerDonkena Krishna Vanaja
Department of Urology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
Clin Cancer Res 12:1128-36. 2006..We analyzed the expression of genes to identify reliable molecular markers in the diagnosis and progression of prostate cancer...
Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001Shomik Sengupta
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 106:2630-5. 2006..A chronological change in pathologic grading classification is suggested by evolving prognostic implications, which must be accounted for when comparing outcomes from different eras...
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survivalW Scott Webster
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 107:46-53. 2006..61; P = .028). CONCLUSIONS: Mononuclear cell infiltration is associated with death from RCC even after multivariate adjustment. Routine documentation of mononuclear cell infiltration is recommended during the pathologic assessment of RCC...
Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomyShomik Sengupta
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Urology 68:94-8. 2006..CONCLUSIONS: The results of our study have shown that the likelihood of +SMs at RRP is best predicted on the basis of conventional prognostic factors. The DIA features of needle biopsies did not provide additional predictive power...
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trialsBradley C Leibovich
Department of Urology, Mayo Medical School, Rochester, Minnesota, USA
J Urol 174:1759-63; discussion 1763. 2005..We developed a clinically useful scoring algorithm to predict cancer specific survival for patients with clear cell metastatic renal cell carcinoma (RCC)...
Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinomaAlexander Scott Parker
Department of Urology, Mayo Clinic, Jacksonville, FL 32224, USA
Hum Pathol 38:453-61. 2007..Data from this investigation are the first to suggest that loss of TbetaRII expression is associated with improved ccRCC patient survival, especially among those patients with less aggressive disease profiles at time of surgery...
Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinomaAmy E Krambeck
Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, MN 55905, USA
Clin Cancer Res 13:1749-56. 2007..Herein, we examine the clinical effect of ccRCC combined expression of both survivin and B7-H1...
A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic diseaseMasahiro Yanagisawa
Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA
J Biol Chem 283:18344-54. 2008..The data indicate that the increased expression of p120 isoform 1 during tumor progression contributes to the invasive phenotype of cadherin-deficient carcinomas and that the N-terminal domain of p120 is a valid therapeutic target...
Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocolSameer A Siddiqui
Department of Urology, Mayo Clinic, Rochester, MN, USA
BJU Int 104:778-85. 2009....
Renal carcinoid tumor: a clinicopathologic study of 21 casesDonna E Hansel
Department of Pathology and Laboratory Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Am J Surg Pathol 31:1539-44. 2007..Of the remaining patients, 7 patients were alive without disease and 6 patients were alive with disease. Additional metastases developed in 4 patients and included metastases to the liver and bone...
Prediction of radial distance of extraprostatic extension from pretherapy factorsDavid J Schwartz
Department of Radiation Oncology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 69:411-8. 2007..In this study, the correlation of the EPEr from a large whole mount prostatectomy series was determined with respect to the needle biopsy and prostatectomy specimen findings...
Making anatomic terminology of the prostate and contiguous structures clinically useful: historical review and suggestions for revision in the 21st centuryRobert P Myers
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin Anat 23:18-29. 2010..Finally, we provide a new table of terms for the prostate with recommended amendments and deletions to existing official nomenclature as contained in the 1998 Terminologia Anatomica...
Histological subtype is an independent predictor of outcome for patients with renal cell carcinomaBradley C Leibovich
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 183:1309-15. 2010..We examined the significance of histological subtype on progression to distant metastasis and cancer specific death after nephrectomy...
Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinomaMahul B Amin
Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
Am J Surg Pathol 33:384-92. 2009..In light of the distinctive clinicopathologic features and a low but definite metastatic potential, this unique subtype of renal cell carcinoma deserves formal recognition in the contemporary classification of renal neoplasms...
The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG statusR Jeffrey Karnes
Department of Urology, Laboratory Medicine and Pathology, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer Res 70:8994-9002. 2010..In addition, although patient numbers are small, the response to adjuvant androgen deprivation therapy is associated with ERG status, showing more significant treatment effect in ERG(+) patients...
High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinomaAlexander S Parker
Department of Urology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA
Cancer 107:37-45. 2006..What remained in question was whether survivin expression at the protein level is an independent predictor of disease progression and cancer-specific survival...
Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?R Houston Thompson
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 174:1218-21. 2005..We investigated the prognostic significance of each of these pathological features using a cohort of pT3a patients...
Adenomatoid tumor of the adrenal gland: a clinicopathologic study of five cases and review of the literaturePhillip A Isotalo
Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 27:969-77. 2003..6%). In three cases with clinical follow-up, no recurrence or metastases occurred. Adrenal gland adenomatoid tumors are morphologically and immunophenotypically identical to adenomatoid tumors of the genital tract and appear benign...
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombusMichael L Blute
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
BJU Int 94:33-41. 2004..To report the surgical management, complications and outcomes over three decades by tumour thrombus level for patients with renal cell carcinoma (RCC) and renal venous extension, as surgery is the most effective treatment...
Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survivalAlexander S Parker
Department of Urology, Mayo College of Medicine, Jacksonville, Florida 32224, USA
Cancer 100:2577-82. 2004..The authors conducted a case-cohort investigation to examine the association of insulin-like growth factor I receptor (IGF-IR) expression and disease-specific survival in patients who underwent surgery for pT1 CC-RCC...
The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostateGloria R Mora
Department of Urology Research, Mayo Clinic, Rochester, MN 55905, USA
Mol Cancer Res 2:115-28. 2004..Thus, we add the novel concept that microtubules regulate EGR-1 localization in benign prostate cells but not in malignant prostate cells...
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomyBradley C Leibovich
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 171:1066-70. 2004..We compared outcomes between patients treated with nephron sparing surgery (NSS) without imperative indications for renal preservation and radical nephrectomy (RN) for 4 to 7 cm renal cell carcinoma (RCC)...
Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcomaScott A Martin
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 26:292-300. 2002..In addition, the diagnosis of urinary bladder leiomyoma should be reserved for noninfiltrative smooth muscle tumors lacking mitotic activity, cytologic atypia, and necrosis...
Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancerThomas J Sebo
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 26:431-9. 2002..Cancer progression models that include serum prostate specific antigen and clinical stage may require revision to incorporate perineural invasion and MIB-1 proliferative activity in addition to Gleason score...
Cysteine-rich secretory protein-3: a potential biomarker for prostate cancerFarhad Kosari
Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Cancer Epidemiol Biomarkers Prev 11:1419-26. 2002..These findings suggest that CRISP-3 is a potential biomarker for prostate cancer...
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trialsBradley C Leibovich
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 97:1663-71. 2003....
Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcomeIgor Frank
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 97:2425-31. 2003..However, some patients are cured by radical cystectomy alone. The goal of this study was to identify predictors of survival in this cohort...
A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinomaMichael L Blute
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 172:465-9. 2004....
Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinomaAlexander S Parker
Department of Urology, Mayo Clinic Jacksonville, Jacksonville, Florida 32224, USA
Urology 65:1090-5. 2005..Recent data have suggested that somatic mutations of the VHL tumor suppressor gene are associated with better cancer-specific survival in patients with CC-RCC...
Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohortIgor Frank
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
J Urol 173:1889-92. 2005..In the current study we evaluated the 2002 primary tumor classification and compared its predictive ability with that of the 1997 classification...
Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?R Houston Thompson
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 173:918-21. 2005..In the current study we evaluated the association of direct ipsilateral adrenal invasion with outcome to determine if reclassification of these tumors as pT4 would improve the accuracy of the current tumor classification...
Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?Bradley C Leibovich
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 173:716-9. 2005..We evaluated the association of tumor thrombus level and fat invasion with outcome to determine if further subclassification would improve the prognostic accuracy of the current classification...
pT2 classification for renal cell carcinoma. Can its accuracy be improved?Igor Frank
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 173:380-4. 2005..In this study we determined whether a size cutoff point exists within pT2 tumors and whether such subclassification would further improve the accuracy of the current tumor classification...
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvementIgor Frank
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 101:1803-8. 2004..The objective of this study was to assess the ability of these markers to predict disease-associated outcomes and response to chemotherapy in a cohort of patients with LN-positive TCC...
Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a reviewW K Lau
Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
BJU Int 91:775-9. 2003..Hence, in the era of cytoreductive surgery, the removal of solitary contralateral adrenal metastasis seems to be indicated...
Juxtaglomerular cell tumor: a clinicopathologic study of four cases and review of the literatureS A Martin
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Am J Clin Pathol 116:854-63. 2001..There were no recurrences or metastases. The characteristic clinical and morphologic features of juxtaglomerular cell tumor permit distinction from renal hemangiopericytoma and other renal tumors...
Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patientsAhmad H Bani-Hani
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 173:391-4. 2005....
PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expressionH Huang
Department of Urology Research, Mayo Foundation, Rochester, Minnesota 55905, USA
J Biol Chem 276:38830-6. 2001..These findings suggest that the PTEN gene and its regulated pathway are potential therapeutic targets in prostate cancer...
Transitional cell carcinoma of the bladder mimicking recurrent paget's disease of the vulva: report of two cases, with one occurring in a myocutaneous flapC H Boardman
Department of Obstetrics and Gynecology, Division of Anatomic Pathology, 200 First Street SW, Rochester, Minnesota, 55905, USA
Gynecol Oncol 82:200-4. 2001..CONCLUSION: If the history of the patient includes transitional cell carcinoma of the bladder and vulvar Paget's disease, histologic evaluation is needed for accurate diagnosis and proper treatment...
Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinomaAlexander S Parker
Department of Urology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Hum Pathol 39:1176-84. 2008..Thus, visual assessment represents an economical, widely available, and reliable method to assess survivin as a predictor of clear cell renal cell carcinoma patient outcomes...
Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal massesMichael D Gillett
Division of Urology, Southern Illinois University, Springfield, Illinois, USA
J Urol 173:1893-6. 2005..These factors likely contributed to improved cancer specific survival for younger patients...
Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinomaSameer A Siddiqui
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin Cancer Res 13:2075-81. 2007..We tested for the presence of putative Tregs within renal cell carcinoma (RCC) tumors...
Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinomaW Scott Webster
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Urology 70:900-4; discussion 904. 2007..However, long-term outcome data are lacking. We reviewed our experience with RCC and report on pathologic features and patient outcome associated with the cystic variant...
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomyR Houston Thompson
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
J Urol 179:468-71; discussion 472-3. 2008..We reviewed our surgical experience with small renal tumors, comparing overall survival in patients treated with radical and partial nephrectomy...
Frequent microsatellite instability in sporadic tumors of the upper urinary tractArndt Hartmann
Institute of Pathology, University of Regensburg, 93042 Regensburg, Germany
Cancer Res 62:6796-802. 2002....
Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinomaAlexander Parker
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 170:420-4. 2003..CONCLUSIONS: Evidence from this investigation is consistent with laboratory data suggesting that IGF-IR expression is associated with CC-RCC survival and could potentially represent a molecular avenue for therapeutic intervention...
Re: Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. V. Margulis, P. Tamboli, S. F. Matin, M. Meisner, D. A. Swanson and C. G. Wood. J Urol 2007; 178: 1878-1882R Houston Thompson
J Urol 180:409; author reply 409-10. 2008
Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrenceMichael L Blute
Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Urol 170:760-3. 2003..The metachronous contralateral recurrence rate for patients with sporadic multifocal lesions is approximately 5%. Planned NSS may not be abandoned if satellite lesions are benign...
